By Associate Professor Natasa Gisev

Journal articles

Chen TF; Gisev N; O'Reilly C; Nishtala P; Bell JS, 2009, 'Mind games: Pharmacists and mental health', Australian Journal of Pharmacy, 90, pp. 70 - 72

Gisev N; Bell JS; McLachlan AJ; Chetty M; Chen TF, 2006, 'Psychiatric drug use among patients of a community mental health service: Patterns and implications', Disease Management and Health Outcomes, 14, pp. 369 - 376, http://dx.doi.org/10.2165/00115677-200614060-00006

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International journal of population data science, 7

Conference Papers

Hopkins R; Bharat C; Buizen L; Close J; Ivers R; Draper B; Pearson S-A; Degenhardt L; Gisev N, 2024, '181 Age-related risk of serious fall events associated with opioid analgesic use', in Abstracts, BMJ Publishing Group Ltd, pp. A35.1 - A35, presented at 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) abstracts, http://dx.doi.org/10.1136/injuryprev-2024-safety.83

Gisev N; Buizen L; Schaffer A; Daniels B; Pearson S-A; Dobbins T; Blyth F; Larney S; Currow DC; Wilson A; Degenhardt L, 2022, '| New South Wales, Long-term trajectories of prescription opioid use in New South Wales, Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 371 - 372, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084401349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Pearson S-A; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow D; Mattick R; Degenhardt L, 2021, 'POPPY II cohort profile- a population-based linked cohort examining the course and outcomes of prescription opioid use in NSW, Australia, 2003-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 300 - 301, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300611&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N, 2017, 'The safety of transdermal fentanyl initiation in Australian clinical practice', Brisbane, Australia, presented at 2017 Australasian Pharmaceutical Scientific Association - Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Joint Scientific Meeting, Brisbane, Australia, 05 December 2017 - 08 December 2017

Gisev N, 2017, 'Quantifying the extent that data from PBS/RPBS claims under-estimate opioid analgesic utilisation in Australia', Brisbane, Australia, presented at 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, 29 October 2017 - 31 October 2017

Gisev N, 2017, 'An ecological study of the extent and factors associated with the use of fentanyl across Australia', Brisbane, Australia, presented at 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, 29 October 2017 - 31 October 2017

Gisev N, 2016, 'Does Size Really Matter? Using Big Data to Examine the Patterns and Predictors of Opioid Utilisation in Australia', Sydney, Australia, presented at 2016 Australasian Pharmaceutical Science Association Annual Conference, Sydney, Australia, 02 December 2016 - 05 December 2016

Gisev N, 2015, 'An ecological study of the extent and factors associated with use of prescription and over-the-counter codeine in Australia', presented at 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, 29 November 2015 - 02 December 2015

Gisev N, 2015, 'Opioid Substitution Therapy among Prisoners: Longitudinal Findings from a Data Linkage Study', Hobart, Australia, presented at 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, Hobart, Australia, 29 November 2015 - 02 December 2015

Gisev N, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon release from prison', presented at 2015 Australasian Professional Society on Alcohol and Other Drugs Conference, 08 November 2015 - 11 November 2015

Gisev N, 2015, 'Estimating the extent and predictors of pharmaceutical opioid use in Australia in 2013', presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015

Gisev N, 2015, 'The effect of treatment and retention with opioid substitution therapy in reducing crime among opioid-dependent people', presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015

Gisev N, 2014, 'Treatment utilisation and retention with opioid substitution therapy: comparison of buprenorphine and methadone users', presented at 2014 Australasian Professional Society on Alcohol and Other Drugs Conference, 09 November 2014 - 12 November 2014

Gisev N, 2014, 'The impact of opioid substitution therapy on mortality post-release from prison: A retrospective data linkage study', presented at 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 24 October 2014 - 27 October 2014

Gisev N, 2014, 'Treatment utilisation and retention with opioid substitution therapy between 2001 and 2010: A comparison of buprenorphine and methadone users', presented at 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 24 October 2014 - 27 October 2014

Gisev N, 2014, 'The cost effectiveness of opioid substitution therapy and impact on criminal offending and mortality.', presented at National Drug and Alcohol Research Centre 2014 Annual Symposium, 08 September 2014 - 08 September 2014

Gisev N; Bell JS; Chen TF, 2011, 'COMMUNITY TREATMENT ORDERS FOR INDIVIDUALS WITH A MENTAL ILLNESS IN NEW SOUTH WALES: A DESCRIPTIVE ANALYSIS OF PSYCHOTROPIC DRUG USE', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, pp. A36 - A36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290992200113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Gisev N; Degenhardt L; Buckley N; Larney S; Dobbins T; Pearson S, 2017, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Vol. 26, pp. 106 - 106, presented at National Drug and Alcohol Research Centre 2017 Annual Symposium, 03 October 2017 - 04 October 2017

Gisev N, 2017, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', presented at 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 26 August 2017 - 30 August 2017

Gisev N, 2016, 'Characteristics of a population-based cohort initiating strong prescription opioids in Australia and factors associated with the type of opioid initiated', presented at National Drug and Alcohol Research Centre 2016 Annual Symposium, 12 September 2016 - 12 September 2016

Gisev N, 2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 25 August 2016 - 28 August 2016

Gisev N, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon release in reducing mortality among prisoners with a history of opioid dependence', presented at National Drug and Alcohol Research Centre 2015 Annual Symposium, 15 September 2015 - 15 September 2015

Gisev N, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon release in reducing mortality among prisoners with a history of opioid dependence', presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015

Gisev N, 2014, 'Opioid substitution therapy utilisation among opioid-dependent men and women: A population-based comparative study', presented at National Drug and Alcohol Research Centre 2014 Annual Symposium, 08 September 2014 - 08 September 2014

Gisev N; Larney S; Burns L; Degenhardt L, 2013, 'Opioid substitution therapy in New South Wales 2001-2012: Comparison between buprenorphine and methadone users', Vol. 146, pp. e234 - e235, presented at National Drug and Alcohol Research Centre 2013 Annual Symposium, 04 September 2013 - 04 September 2013, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.105

Gisev N, 2013, 'Engagement with the criminal justice system among opioid-dependent people: Comparison between Indigenous and non-Indigenous offenders', presented at National Drug and Alcohol Research Centre 2013 Annual Symposium, 04 September 2013 - 04 September 2013

Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2012, 'Mortality associated with benzodiazepine use among community-dwelling older people: results from a population-based retrospective cohort study in Finland', presented at National Medicines Symposium 2012, 24 May 2012 - 25 May 2012

Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2012, 'The risk of death associated with antipsychotic use in community-dwelling older adults: do co-morbidities make a difference?', presented at National Medicines Symposium 2012, 24 May 2012 - 25 May 2012

Conference Presentations

Hopkins R; Bharat C; Chambers M; Degenhardt L; Peacock A; Farrell M; Yuen WS; Man N; Gisev N, 2024, 'Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980-2019', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=554s

Bharat C; Gisev N; Hopkins R; Pearson SA; Gillies M; Dobbins T; Larney S; Blythe F; Degenhardt L, 2024, 'Development of opioid use disorder following treatment with opioid analgesics for non-cancer pain relief: an Australian state-wide nested case-control study', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=SwVO9ONBuE8&t=5295s

Hopkins R, 2023, '“We didn’t cause the opioid epidemic”: The experience of being prescribed opioids for chronic non-cancer pain at a time of increasing restrictions', presented at Australian Pain Society 43rd Annual Scientific Meeting, Canberra, Australia, 02 April 2023

Schaffer A; Cairns R; Brown J; Gisev N; Buckley N; Pearson S, 2020, 'Changes in sales of over‐the‐counter and prescription medicines after rescheduling of codeine to a prescription‐only medicine in Australia', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Conference Abstracts

Santo T; Gisev N; Campbell G; Colledge-Friday S; Wilson J; Tran LT; Lynch M; Martino-Burke D; Taylor S; Degenhardt L, 2024, 'Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis', in International Journal of Drug Policy, Vol. 128, http://dx.doi.org/10.1016/j.drugpo.2024.104434

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, Vol. 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Reports

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney; NDARC, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chrzanowska A; Gisev N; Price O; Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2020, Tapentadol use and harms in Australia: Analysis of opioid sales data and sentinel survey data from people who inject drugs, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef15b883c0ac

Gisev N; Larney S; Kimber J; Burns L; Weatherburn D; Gibson A; Dobbins T; Mattick R; Butler T; Degenhardt L, 2014, Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 330, https://ndarc.med.unsw.edu.au/resource/determining-impact-opioid-substitution-therapy-upon-mortality-and-recidivism-among

Nielsen S; Degenhardt L; Hoban B; Gisev N, 2014, Comparing opioids: A guide to estimating oral morphine equivalents (OME) in research, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 329, https://ndarc.med.unsw.edu.au/resource/comparing-opioids-guide-estimating-oral-morphine-equivalents-ome-research

Theses / Dissertations

Gisev N, 2014, An Evaluation of Psychotropic Medicines Use: Patterns and Outcomes

Back to profile page